Significance of Aneuploidy in Melanoma of the Extremity
|
|
- Randell George
- 5 years ago
- Views:
Transcription
1 Significance of Aneuploidy in elanoma of the xtremity. W. van Oven,.D.,*. C. Baas,.D.,t J. W. Oosferhuis,.D., h.d.,* H. Schraffordf Koops,.D., h.d.,t and A. Dameiring, B.S.* 09 Tumor nuclear DNA content was determined by flow cytometry in routinely prepared paraffin blocks from 2 primary malignant melanomas of the extremities. Twelve of the tumors were aneuploid, and 3 were euploid. n this series the presence of aneuploidy appeared to have no prognostic value. Cancer 992; 70:093. Key words: melanoma, DNA flow cytometry, ploidy, aneuploidy. The prognosis for patients with primary cutaneous malignant melanoma depends on clinical stage, localization of the tumor, and treatment and can be correlated with a variety of morphologic parameters, among which the most predictive factor seems to be the depth of invasion (Breslow thickness).' However, more and stronger prognostic factors would be welcome and could be helpful in assessing appropriate therapy because there is still uncertainty about the adequate margin of excision and the benefit of regional chemotherapy by isolated regional perfusion. low cytometric DNA analysis appears to have significant value for establishing prognosis in many solid tumors.' n this study the cellular DNA content of a series of melanomas is assessed by means of flow cytometry of paraffinembedded tissue. The results are compared with survival and histologic features of the tumors. atients and ethods Twentynine patients were selected who were treated for melanoma of the extremities between 973 and stage, treatment, tumor thickness, and availability of paraffin blocks. Data of 2 of 29 cases were evaluable (Table ). The series included patients with longterm survival (3 patients) and patients who died as a result of their cancer (2 patients). All patients had malignant melanoma of the extremity; 2 patients had a malignant melanoma of the lower extremity and patients had melanoma of the upper extremity. All patients had Stage A disease according to the. D. Anderson classification. n all cases, treatment consisted of local excision, axillary or iliac node dissection, and hyperthermic isolated perfusion with melphalan. Thirteen patients were female and 2 patients were male. The mean age was 2 years. ollowup for survivors was at least 30 months. The thinnest lesion was a melanoma with a Breslow thickness of at least. mm; thinner lesions were not included to avoid measurements on tissue not representative of the lesion. All histologic sections of the lesions were analyzed by an experienced pathologist (J.W.O.) who had no knowledge of the flow cytometry results. The sections were scored on the following parameters (see Table ): Breslow thickness, Clark level, shape, presence of ulceration, presence of superficial spreading component, number of mitoses, presence of atypical mitoses, cell type, amount of lymphocytic infiltration, and presence of angoinvasion. Nuclear suspensions were made according to methods described by Hedley et with minor modifications. Briefly, 0pmthick sections were cut from representative parts of the paraffin blocks, selected with the use of adjacent hematoxylin and eosinstained his 98 at the Of oncology Of the tologic slides. These were dewaxed in xylene, r&y University Hospital of Groningen. drated in decreasing concentrations of alcohol, and sus The selection of patients was based on survival pended in pepsin. The resultant naked nuclei were (short or long), localization of primary tumor, clinical stained with propidium iodide after RNase digestion, rom the Departments of *athology and tsurgical Oncology, University Hospital of Groningen, Groningen, The Netherlands. Address for reprints:. W. van Oven,.D., Department of athology, University of Groningen, Oostersingel63,973 Z Groningen, The Netherlands. Accepted for publication October, 99. filtered through nylon gauze, and run through an ACS 0 flow cytometer (Becton Dickinson, ttenleur, The Netherlands). The leftmost peak in the histograms was considered to represent the diploid GO/G phase nuclei of host or tumor cells. A lesion was considered to contain
2 Table. Clinical Data, Histologic eatures, and loidy of 2 Cases of elanoma of the xtremity Breslow Clark Superficial atient thickness Age classifica Spreading Lymphocytic no. (mm) Sex (vr)* Site Staee tion Shaue Ulceration elanoma itosest Cell twe infiltration Aneioinvasion loidv 00wu~ >. >.7 37 U 3 L 3 U L 0 L 26 L 60 U 29 L 36 L 8 L L 60 L 60 L 3 L 3 L 23 L L 67 L 8 U 7 L L L 30 L 29 L 3 LS > 3 '3 0 2i + f + + k /S f f S /S S /S * /S /S A A A A A A A A A A A A ND (0 yr) DOD after 3 mo ND (2 yr) ND (0 yr) DOD after 8 mo ND (6 yr) DOD after 30 mo DOD after mo DOD after 0 mo DOD after 62 mo ND (30 mo) ND (8 y') DOD after 6 mo DOD after 29 mo ND ( yr) ND (9 yr) ND (6 yr) DOD after mo ND (0 yr) ND (9 yr) DOD after 20 mo DOD after 0 mo DOD after 8 mo ND ( yr) ND 2 vr) U: upper extremity; L: lower extremity; LS: lower extremity subungual; convex or plateau; : polypoid; flat; : epithelioid, /S: mixed epithelioid and spindle; S: spindle; : none or little; +: much; +: moderate; : euploid; A aneuploid; ND: no evidence of disease; DOD: dead of disease. * Age at time of presentation. t Number of mitoses/five highpower fields. resence of atypical mitotic figures.
3 Aneuploidy in elanomaslvan Oven et al igure. xamples of aneuploid DNA histograms. Vertical axis: number of counted events; horizontal axis: channel number, representing the relative DNA content. (Top left) Aneuploid DNA histogram with one aneuploid stem cell line. (Top right) ultiploid DNA histogram with more than one aneudoid stem cell line. (Bottom) Aneuploid DNA histogram with "neardiploid'.' tumor stem cell line. The shoulder on the peak is the result of the presence of two cell populations with DNA indices close to each other. 0 l l l l "WJ' \ L an aneuploid stem cell line if more than one GO/G peak could be identified or when a clear shoulder was present on a single GO/Gl peak or on the G2/ peak. The DNA index for aneuploid populations was calculated as the ratio of the channel of the aneuploid peak divided by the channel of the diploid peak. The coefficient of variation was calculated for the euploid GO/G peak by use of the half maximum peak height. or statistical analysis of data, the chisquare test was used. Results our of the 29 tumors originally processed were excluded from additional evaluation because the quality of the DNA histograms was not acceptable. The poor quality of the histograms probably resulted from fixation of these specimens in Bouin solution. All other lesions had interpretable DNA histograms, with coefficients of variation varying between and. Nine lesions showed an aneuploid pattern with one or more peaks outside the diploid or tetraploid region (ig. la). The DNA indices of these aneuploid peaks varied between.3 and 2.6. One of these histograms showed a multiploid pattern (ig. lb). Three other lesions showed aneuploidy in the form of shoulders being adjacent to GO/G or G2/ peaks (ig. lc). t was concluded that in these lesions aneuploid cell populations were present with DNA indices close to.0 or 2.0. The other 3 histograms showed a euploid pattern, with only one large peak and variable smaller peaks with DNA indices of approximately 2.0, representing G2/ phase tumor and host cells. There was no significant correlation between ploidy and survival ( > 0.0). Of the 2 patients who died of widespread metastatic melanoma, had an aneuploid tumor and 8 a diploid tumor. Of the 3 tumors from survivors (followup of 30 months to 2 years), 8 were aneuploid and the other euploid. There was no significant correlation between the ploidy pattern and tumor thickness when melanomas larger than 3 mm
4 2 CANCR July 2, 2992, Volume 70, No. were compared with those of smaller size. A correlation also was not found between ploidy and sex or site, or between ploidy and the morphologic features of ulceration, mitoses (more than five per five highpower fields versus less than five per five highpower fields), cell type (epithelioid versus combined epithelioid/spindle), lymphocytic infiltration, or presence of superficial spreading component. Although not significant, of the seven tumors with a spindle cell component or composed of spindle cells only, six appeared to contain aneuploid stem cell lines. ive of these tumors had a favorable clinical course and two had an unfavorable course. Discussion One of the advantages of using paraffinembedded tissue for DNA flow cytometry as compared with fresh tissue is that the nature of the tissue analyzed can be verified easily by review of adjacent histologic sections. This is especially important in melanomas because the small size of the tumors and the frequent admixture of inflammatory cells can be responsible for overrepresentation of host cells, obscuring an aneuploid tumor cell population. However, increased amounts of cellular debris and a high baseline noise may prevent the recognition of small aneuploid peaks, and peridiploid or peritetraploid peaks can become invisible because of the higher coefficients of ~ariation.~,~ Therefore, absence of aneuploidy is difficult to prove, despite the presentation of a euploid DNA histogram. To avoid overrepresentation of normal cells, the representative part of the paraffin block was selected carefully with the use of adjacent histologic sections and by excluding thin lesions. The results of the current study do not confirm the findings of some other authors who found relations between aneuploidy and recurrence and between aneuploidy and other unfavorable prognostic factors. Using fresh tissue, Sondergaard et ale6 found heteroploidy in 26 of 3 primary melanomas. Aneuploid cell populations were present in 7 of the tumors. A correlation was found between heteroploidy and thickness of the tumor. urthermore, a correlation was found between heteroploidy and a high mitotic activity and significant nuclear pleomorphism. Von Roenn et al.7 found aneuploidy in 3 of 3 primary melanomas, using paraffin blocks. Twenty melanomas had a thickness of more than. mm; from this group, 9 contained aneuploid cell populations. This percentage is in agreement with findings from the current investigation. n their series, there appeared to be a significant correlation between the presence of aneuploidy and tumor thickness. Also, there appeared to be a correlation with the rate of recurrence. Another study from the same laboratory reported the presence of aneuploidy in 3 of 62 Stage melanomas, 98 with a thickness greater than. mm.' n contrast to the results obtained in the current study, aneuploidy was correlated significantly with tumor thickness and ulceration. Aneuploid tumors smaller than. mm and more than 3 mm thick were associated with a higher recurrence rate and decreased diseasefree interval. The findings in the current study are in accordance with those reported by Zaloudik et al.,9 who found no correlation between DNA ploidy and clinical course in 0 Stage melanomas larger than 2.0 mm. Aneuploidy was found in 3 of the tumors. The total lack of a relationship between aneuploidy and survival in melanomas in this study is disappointing. One has to realize that all patients in the current series have been treated by regional perfusion of the extremity, which may have influenced the results. The absence of a relationship between aneuploidy and lesion thickness is noticeable. Because it is conceivable that aneuploid stem cell lines develop as a result of clonal evolution," such a relationship could be expected to exist; as time passes and the tumor grows, the chance should increase that a detectable aneuploid subline has formed. A second reason to expect such a relationship is a possible tendency for aneuploid tumors to grow faster than euploid tumors. aybe the exclusion of small lesions in this series has been of influence. The absence of a correlation between aneuploidy and recurrence in combination with the absence of a correlation between aneuploidy and tumor thickness favors the possibility that the biologic potential of melanomas is totally independent of ploidy, with aneuploid tumors not growing faster and not giving rise to early metastases. Without indicating that such a relationship does not exist, however, the results of the current investigation permit at least the conclusion that aneuploid melanomas need not be followed by an unfavorable course of disease. t must be explored whether the high incidence of aneuploidy in spindle cell lesions is helpful in the sometimes difficult differential diagnosis between spindle cell melanoma and spindle cell nevi, in particular Spitz nevi. References. Breslow A. Thickness, crosssectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 970; 72: riedlander L, Hedley DW, Taylor W. Clinical and biological
5 Aneuploidy in elanomas/van Oven et al. 3 significance of aneuploidy in human tumors. ] Clin athol 98; Hedley DW, riedlander L, Taylor W, Rugg CA, usgrove A. ethods for analysis of cellular DNA content of paraffinembedded pathological material using flow cytometry. ] Histochem Cyfochem 983; 3:333.. Stephenson RA, Gay H, air WR, elamed R. ffect of section thickness on quality of flow cytometric DNA content determinations in paraffinembedded tissues. Cytometry 986; 7:.. rierson H. low cytometric analysis of ploidy in solid neoplasms: comparison of fresh tissues with formalinfixed paraffin embedded specimens. Hum athol 988; 9: Sondergaard K, Larsen JK, oller U, Christensen J, Houjensen K. DNA ploidycharacteristics of human malignant melanoma analysed by flow cytometry and compared with histology and clinical course. Virchows Arch [B] 983; Von Roenn JH, Kheir S, Wolter J, Coon JS. Significance of DNA abnormalities in primary malignant melanoma and nevi: a retrospective flow cytometric study. Cancer Res 986; 6: Kheir S, Bines SD, Von Roenn JH, Soong S, Urist, Coon JS. rognostic significance of DNA aneuploidy in stage cutaneous melanoma. Ann Surg 988; 207:6. 9. Zaloudik J, oore, Ghosh AK, echl 2, Rejthar A. DNA content and HC class antigen expression in malignant melanoma: clinical course. Clin athol 988; : Nowell C. The clonal evolution of tumor cell populations: acquired genetic lability permits stepwise selection of variant sublines and underlies tumor progression. Science 976; 9:238.
Melanoma-Back to Basics I Thought I Knew Ya! Paul K. Shitabata, M.D. Dermatopathologist APMG
Melanoma-Back to Basics I Thought I Knew Ya! Paul K. Shitabata, M.D. Dermatopathologist APMG At tumor board, a surgeon insists that all level II melanomas are invasive since they have broken through the
More informationMeasurement of c-myc oncogene expression provides an accurate prognostic marker for acral lentiginous melanoma
British Journal of Plastic Surgery (1999), 52, 122 126 1999 The British Association of Plastic Surgeons Measurement of c-myc oncogene expression provides an accurate prognostic marker for acral lentiginous
More informationDavid B. Troxel, MD. Common Medicolegal Situations: Misdiagnosis of Melanoma
Common Medicolegal Situations: Misdiagnosis of Melanoma David B. Troxel, MD Medical Director, The Doctors Company, Napa, California Clinical Professor Emeritus, University of California at Berkeley Past
More informationMALIGNANT MELANOMA OF THE HEEL
MALIGNANT MELANOMA OF THE HEEL Pages with reference to book, From 50 To 53 Fazli M. Qazi ( Departments of Pathology, Khyber Medical College, Peshawar. ) Rahjm Gul ( Departments of Surgery, Khyber Medical
More informationA PRACTICAL APPROACH TO ATYPICAL MELANOCYTIC LESIONS BIJAN HAGHIGHI M.D, DIRECTOR OF DERMATOPATHOLOGY, ST. JOSEPH HOSPITAL
A PRACTICAL APPROACH TO ATYPICAL MELANOCYTIC LESIONS BIJAN HAGHIGHI M.D, DIRECTOR OF DERMATOPATHOLOGY, ST. JOSEPH HOSPITAL OBJECTIVES Discuss current trends and changing concepts in our understanding of
More informationPrognostic value of flow-cytometric DNA analysis in breast cancer
Riv Med Lab - JLM, Vol. 2, N. 4, 2001 17 Prognostic value of flow-cytometric DNA analysis in breast cancer V. Petrozza 1,2, F. Verna 2, L. Lenti 2, F. Carpino 2 1 Department of General Surgery Paride Stefanini
More informationMelanoma Underwriting Presented at 2018 AHOU Conference. Hank George FALU
Melanoma Underwriting Presented at 2018 AHOU Conference Hank George FALU MELANOMA EPIDEMIOLOGY 70-80,000 American cases annually Majority are in situ or thin > 20% are diagnosed age 45 8-9,000 melanoma
More informationMelanoma Case Scenario 1
Melanoma Case Scenario 1 History and physical 11/5/16 Patient is a single, 48-year-old male in good health who presented to his primary physician for a yearly physical exam during which a 3.4 x 2.8 x 1.5
More information6/22/2015. Original Paradigm. Correlating Histology and Molecular Findings in Melanocytic Neoplasms
6 Correlating Histology and Molecular Findings in Melanocytic Neoplasms Pedram Gerami MD, Associate Professor of Dermatology and Pediatrics at Northwestern University Disclosures: I have been a consultant
More informationMelanoma Case Scenario 1
Melanoma Case Scenario 1 History and physical 11/5/16 Patient is a single, 48-year-old male in good health who presented to his primary physician for a yearly physical exam during which a 3.4 x 2.8 x 1.5
More informationPatient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival
MOLECULAR AND CLINICAL ONCOLOGY 7: 1083-1088, 2017 Patient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival FARUK TAS
More informationClinical Pathological Conference. Malignant Melanoma of the Vulva
Clinical Pathological Conference Malignant Melanoma of the Vulva History F/48 Chinese Married Para 1 Presented in September 2004 Vulval mass for 2 months Associated with watery and blood stained discharge
More informationMelanoma Update: 8th Edition of AJCC Staging System
Melanoma Update: 8th Edition of AJCC Staging System Rosalie Elenitsas, M.D. Professor of Dermatology Director, Dermatopathology University of Pennsylvania DISCLOSURE OF RELATIONSHIPS WITH INDUSTRY None
More informationCase Scenario 1 Worksheet. Primary Site C44.4 Morphology 8743/3 Laterality 0 Stage/ Prognostic Factors
CASE SCENARIO 1 9/10/13 HISTORY: Patient is a 67-year-old white male and presents with lesion located 4-5cm above his right ear. The lesion has been present for years. No lymphadenopathy. 9/10/13 anterior
More informationDNA Ploidy Analysis of Borderline Epithelial Ovarian Tumors
DNA Ploidy Analysis of Borderline Epithelial Ovarian Tumors Saba Lodhi,Sabeen Najam,Shahid Pervez ( Department of Pathology, The Aga Khan University Hospital, Karachi. ) Abstract Objective: Borderline
More informationPolypoid Melanoma, A Virulent Variant of the Nodular Growth Pattern
Polypoid Melanoma, A Virulent Variant of the Nodular Growth Pattern ELIZABETH A. MANCI, M.D., CHARLES M. BALCH, M.D..TARIQ M. MURAD, M.D., PH.D., AND SENG/JAW SOONG, PH.D. Manci, Elizabeth A., Balch, Charles
More informationBreslow Thickness and Clark Level Evaluation in Albanian Cutaneous Melanoma
Research DOI: 10.6003/jtad.16104a2 Breslow Thickness and Clark Level Evaluation in Albanian Cutaneous Melanoma Daniela Xhemalaj, MD, Mehdi Alimehmeti, MD, Susan Oupadia, MD, Majlinda Ikonomi, MD, Leart
More informationGenetic Testing: When should it be ordered? Julie Schloemer, MD Dermatology
Genetic Testing: When should it be ordered? Julie Schloemer, MD Dermatology Outline Germline testing CDKN2A BRCA2 BAP1 Somatic testing Gene expression profiling (GEP) BRAF Germline vs Somatic testing
More informationFlow Cytometric Determination of DNA Content in Renal Cell Carcinoma with Special Reference to Tumor Heterogeneity'
The Seoul Journal of Medicine Vol. 32, No. 3: 161-169, September 1991 Flow Cytometric Determination of DNA Content in Renal Cell Carcinoma with Special Reference to Tumor Heterogeneity' Sang Eun Leet2
More informationDesmoplastic Melanoma: Clinical Behavior and Management Implications
Desmoplastic Melanoma: Clinical Behavior and Management Implications Collier S. Pace, MD, a Jyoti P. Kapil, MD, b Luke G. Wolfe, MS, c Brian J. Kaplan, MD, c and James P. Neifeld, MD c a Division of Plastic
More informationEpithelial Cancer- NMSC & Melanoma
Epithelial Cancer- NMSC & Melanoma David Chin MB, BCh, BAO, LRCP, LRCS (Ireland) MCh(MD), PhD (UQ), FRCS, FRACS (Plast) Plastic & Reconstructive Surgeon Visiting Scientist Melanoma Genomic Group & Drug
More informationMalignant tumors of melanocytes : Part 3. Deba P Sarma, MD., Omaha
Malignant tumors of melanocytes : Part 3 Deba P Sarma, MD., Omaha Let s go over one case of melanoma using the following worksheet. Of the various essential information that needs to be included in the
More informationUpdate on 8 th Edition Cutaneous AJCC Staging of Primary Cutaneous Melanoma. Michael T. Tetzlaff MD, PhD
Update on 8 th Edition Cutaneous AJCC Staging of Primary Cutaneous Melanoma Michael T. Tetzlaff MD, PhD Associate Professor Departments of Pathology (Dermatopathology) and Translational and Molecular Pathology
More informationأملس عضلي غرن = Leiomyosarcoma. Leiomyosarcoma 1 / 5
Leiomyosarcoma 1 / 5 EPIDEMIOLOGY Exact incidence is unknown, but older studies suggest that leiomyosarcomas comprise approximately 3 percent of soft-tissue sarcomas. Superficial leiomyosarcoma occurs
More informationDesmoplastic Melanoma R/O BCC. Clinical Information. 74 y.o. man with lesion on left side of neck r/o BCC
R/O BCC Sabine Kohler, M.D. Professor of Pathology and Dermatology Dermatopathology Service Stanford University School of Medicine Clinical Information 74 y.o. man with lesion on left side of neck r/o
More informationVernon K. Sondak. Department of Cutaneous Oncology Moffitt Cancer Center Tampa, Florida
Vernon K. Sondak Department of Cutaneous Oncology Moffitt Cancer Center Tampa, Florida Australasian Melanoma Conference 2016 Sydney, NSW, Australia October 29, 2016 Disclosures Dr. Sondak is a compensated
More informationMalignant Melanoma in Turkey: A Single Institution s Experience on 475 Cases
Malignant Melanoma in Turkey: A Single Institution s Experience on 475 Cases Faruk Tas, Sidika Kurul, Hakan Camlica and Erkan Topuz Institute of Oncology, Istanbul University, Istanbul, Turkey Received
More informationWorld Articles of Ear, Nose and Throat Page 1
World Articles of Ear, Nose and Throat ---------------------Page 1 Primary Malignant Melanoma of the Tongue: A Case Report Authors: Nanayakkara PR*, Arudchelvam JD** Ariyaratne JC*, Mendis K*, Jayasekera
More informationUpdate: Morphologic Considerations in Mesothelioma within the Pleural and Peritoneal Cavities. Douglas J. Hartman, MD June 7, 2018
Update: Morphologic Considerations in Mesothelioma within the Pleural and Peritoneal Cavities Douglas J. Hartman, MD June 7, 2018 Objectives Review Historical Features associated with prognosis Present
More informationRebecca Vogel, PGY-4 March 5, 2012
Rebecca Vogel, PGY-4 March 5, 2012 Historical Perspective Changes In The Staging System Studies That Started The Talk Where We Go From Here Cutaneous melanoma has become an increasingly growing problem,
More information1
www.clinicaloncology.com.ua 1 Prognostic factors of appearing micrometastases in sentinel lymph nodes in skin melanoma M.N.Kukushkina, S.I.Korovin, O.I.Solodyannikova, G.G.Sukach, A.Yu.Palivets, A.N.Potorocha,
More informationDermatopathology: The tumor is composed of keratinocytes which show atypia, increase mitoses and abnormal mitoses.
Squamous cell carcinoma (SCC): A common malignant tumor of keratinocytes arising in the epidermis, usually from a precancerous condition: 1- UV induced actinic keratosis, usually of low grade malignancy.
More informationPrognostic Variables and Surgical Management of Foot Melanoma: Review of a 25-Year Institutional Experience
Virginia Commonwealth University VCU Scholars Compass Surgery Publications Dept. of Surgery 11 Prognostic Variables and Surgical Management of Foot Melanoma: Review of a 5-Year Institutional Experience
More informationDisorders of Cell Growth & Neoplasia. Histopathology Lab
Disorders of Cell Growth & Neoplasia Histopathology Lab Paul Hanna April 2010 Case #84 Clinical History: 5 yr-old, West Highland White terrier. skin mass from axillary region. has been present for the
More informationProtocol applies to melanoma of cutaneous surfaces only.
Melanoma of the Skin Protocol applies to melanoma of cutaneous surfaces only. Procedures Biopsy (No Accompanying Checklist) Excision Re-excision Protocol revision date: January 2005 Based on AJCC/UICC
More informationThe diagnostic and prognostic value of genetic aberrations in resectable distal bile duct cancer Rijken, A.M.
UvA-DARE (Digital Academic Repository) The diagnostic and prognostic value of genetic aberrations in resectable distal bile duct cancer Rijken, A.M. Link to publication Citation for published version (APA):
More informationAmong the benign intraepithelial melanocytic proliferations, Inflamed Conjunctival Nevi. Histopathological Criteria. Resident Short Reviews
Resident Short Reviews Inflamed conjunctival nevi (ICN) may suggest malignancy because of their rapid growth and atypical histology. The objective of this study was to characterize the diagnostic features
More informationMorphological characteristics of the primary tumor and micrometastases in sentinel lymph nodes as a predictor of melanoma progression
Morphological characteristics of the primary tumor and micrometastases in sentinel lymph nodes as a predictor of melanoma progression M.N. Kukushkina, S.I. Korovin, O.I. Solodyannikova, G.G. Sukach, A.Yu.
More informationRELATIONSHIP OF DNA PLOIDY AND S-PHASE FRACTION TO SURVIVAL AFTER FIRST RECURRENCE OF BREAST CANCER
~ Act0 Oncologica Vol. 33, No. 4, pp. 423-429, 1994 RELATIONSHIP OF DNA PLOIDY AND S-PHASE FRACTION TO SURVIVAL AFTER FIRST RECURRENCE OF BREAST CANCER OLLE STAL, JOHN M. CARSTENSEN, STEN WINGREN, LARS
More informationCatholic University of Louvain, St - Luc University Hospital Head and Neck Oncology Programme. Anatomopathology. Pathology 1 Sept.
Anatomopathology Pathology 1 Anatomopathology Biopsies Frozen section Surgical specimen Peculiarities for various tumor site References Pathology 2 Biopsies Minimum data, which should be given by the pathologist
More informationCase 26 Male 37. Right jawline 5mm nodule?keloid. The best diagnosis is:
Case 26 Male 37. Right jawline 5mm nodule?keloid. The best diagnosis is: A. Desmoplastic Spitz naevus B. Atypical Spitz Tumour C. Spitzoid melanoma D. Deep penetrating naevus E. Spitz naevus Case 26: M
More informationQuality ID #397: Melanoma Reporting National Quality Strategy Domain: Communication and Care Coordination
Quality ID #397: Melanoma Reporting National Quality Strategy Domain: Communication and Care Coordination 2018 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY MEASURE TYPE: Outcome DESCRIPTION: Pathology
More informationTHYMIC CARCINOMAS AN UPDATE
THYMIC CARCINOMAS AN UPDATE Mark R. Wick, M.D. University of Virginia Medical Center Charlottesville, VA CARCINOMA OF THE THYMUS General Clinical Features No apparent gender predilection Age range of 35-75
More informationCorrelation of DNA Content and Histology in Prognosis of Astrocytomas
Correlation of Content and Histology in Prognosis of Astrocytomas STEPHEN W. COONS, M.D., JOHN R. DAVIS, M.D., AND DENNIS L. WAY, B.S. Thirty-two cases of astrocytoma were analyzed for content and cell-cycle
More informationWHAT DOES THE PATHOLOGY REPORT MEAN?
Melanoma WHAT IS MELANOMA? Melanoma is a type of cancer that affects cells called melanocytes. These cells are found mainly in skin but also in the lining of other areas such as nose and rectum, and also
More informationORIGINAL ARTICLE. Pathologic Features of Prognostic Significance for Adrenocortical Carcinoma After Curative Resection. with adrenocortical carcinoma
ORIGINAL ARTICLE Pathologic Features of Prognostic Significance for Adrenocortical Carcinoma After Curative Resection Lawrence E. Harrison, MD; Paul B. Gaudin, MD; Murray F. Brennan, MD Objective: To identify
More informationPrognostic value of tumour thickness in cutaneous malignant melanoma
J Clin Pathol 1983;36:51-56 Prognostic value of tumour thickness in cutaneous malignant melanoma IONA JEFFREY, PATRICK ROYSTON, CHRISTOPHER SOWTER, GERARD SLAVIN, ASHLEY PRICE, ARIELA POMERANCE,* SALEEM
More informationDesmoplastic Melanoma: Surgical Management and Adjuvant Therapy
Desmoplastic Melanoma: Surgical Management and Adjuvant Therapy Dale Han, MD Assistant Professor Department of Surgery Section of Surgical Oncology No disclosures Background Desmoplastic melanoma (DM)
More informationCase Report A Rare Cutaneous Adnexal Tumor: Malignant Proliferating Trichilemmal Tumor
Case Reports in Medicine Volume 2015, Article ID 742920, 4 pages http://dx.doi.org/10.1155/2015/742920 Case Report A Rare Cutaneous Adnexal Tumor: Malignant Proliferating Trichilemmal Tumor Omer Alici,
More informationHistopathology of Melanoma
THE YALE JOURNAL OF BIOLOGY AND MEDICINE 48, 409-416 (1975) Histopathology of Melanoma G. J. WALKER SMITH Department ofpathology, Yale University School ofmedicine, 333 Cedar Street, New Haven, Connecticut
More informationAndre W. van Zyl, Marlene B van Heerden, Emil Langenegger, Willie F.P. van Heerden
Correlation between Dysplasia and Ploidy Status in Oral Leukoplakia Andre W. van Zyl, Marlene B van Heerden, Emil Langenegger, Willie F.P. van Heerden AW van Zyl, E Langenegger Department of Periodontics
More informationTracking skin cancers and melanoma at the microscopic level
Tracking skin cancers and melanoma at the microscopic level Rosalie Elenitsas, M.D. Professor of Dermatology Director of Dermatopathology Hospital of the University of Pennsylvania May 12, 2017 Outline
More informationMelanoma. Kaushik Mukherjee MD A. Scott Pearson MD
Melanoma Kaushik Mukherjee MD A. Scott Pearson MD Disclosures You still have to study Not all inclusive No Western blots Extensive use of Google Image Search and Sabiston Melanoma Basics 8 th most common
More informationInternational Society of Gynecological Pathologists Symposium 2007
International Society of Gynecological Pathologists Symposium 2007 Anais Malpica, M.D. Department of Pathology The University of Texas M.D. Anderson Cancer Center Grading of Ovarian Cancer Histologic grade
More informationClassification of Neoplasms
Classification of Neoplasms ICD-10 Chapter 2, Neoplasms Codes C00-D48 Notes at beginning of Chapter 2 Classified by behaviour and site Correct use of Alphabetic index required Main terms Modifiers Table
More informationInteresting Case Series. Desmoplastic Melanoma
Interesting Case Series Desmoplastic Melanoma Anthony Maurice Kordahi, MD, Joshua B. Elston, MD, Ellen M. Robertson, MD, and C. Wayne Cruse, MD Division of Plastic Surgery, Department of Surgery, University
More informationFine-Needle Aspiration and Cytologic Findings of Surgical Scar Lesions in Women With Breast Cancer
148 Fine-Needle Aspiration and Cytologic Findings of Surgical Scar Lesions in Women With Breast Cancer Ehud Malberger, DMD, FIAC,* Yeouda Edoute, MD, PhD,t Osnaf Toledano, MD,* and Dov Sapir, MDS Benign
More informationTalk to Your Doctor. Fact Sheet
Talk to Your Doctor Hearing the words you have skin cancer is overwhelming and would leave anyone with a lot of questions. If you have been diagnosed with Stage I or II cutaneous melanoma with no apparent
More informationCutaneous Melanoma: Epidemiology (USA) The Sentinel Node in Head and Neck Melanoma. Cutaneous Melanoma: Epidemiology (USA)
The Sentinel Node in Head and Neck Melanoma Cutaneous Melanoma: Epidemiology (USA) 6 th leading cause of cancer among men and women 68,720 new cases of invasive melanoma in 2009 8,650 deaths from melanoma
More informationDiagnostic problems in uterine smooth muscle tumors
Diagnostic problems in uterine smooth muscle tumors Marina Kos Ljudevit Jurak Clinical Department of Pathology, Clinical Hospital Center Sestre milosrdnice, Zagreb Institute of Pathology, University of
More informationMichael T. Tetzlaff MD, PhD
American Joint Cancer Committee (AJCC) staging system for primary cutaneous melanoma (8 th Edition) and principles of sentinel lymph node evaluation Emphasis on concise and accurate reporting of primary
More informationSkin Malignancies Non - Melanoma & Melanoma Marilyn Ng, MD Dept. of Surgery M&M Conference Downstate Medical Center July 19, 2012
Skin Malignancies Non - Melanoma & Melanoma Marilyn Ng, MD Dept. of Surgery M&M Conference Downstate Medical Center July 19, 2012 Case Presentation 57 yo man with 3 month hx of a nonhealing < 1 cm right
More informationPrognostic Importance of the Mitotic Marker Phosphohistone H3 in Cutaneous Nodular Melanoma
ORIGINAL ARTICLE Prognostic Importance of the Mitotic Marker Phosphohistone H3 in Cutaneous Nodular Melanoma Rita G. Ladstein 1, Ingeborg M. Bachmann 1,2, Oddbjørn Straume 1 and Lars A. Akslen 1,3 Mitotic
More informationControversies and Questions in the Surgical Treatment of Melanoma
Controversies and Questions in the Surgical Treatment of Melanoma Giorgos C. Karakousis, M.D. Assistant Professor of Surgery Division of Endocrine and Oncologic Surgery University of Pennsylvania School
More informationPrognostic importance of DNA flow cytometry in
J Clin Pathol 1986;39:542-546 Prognostic importance of DNA flow cytometry in non-hodgkin's lymphomas JC MACARTNEY,* RS CAMPLEJOHN,t JULIE ALDER,f MG STONE,I GILL POWELL* From the *Department ofhistopathology,
More informationMeasure #397: Melanoma Reporting National Quality Strategy Domain: Communication and Care Coordination
Measure #397: Melanoma Reporting National Quality Strategy Domain: Communication and Care Coordination 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Outcome DESCRIPTION: Pathology reports
More informationResearch Article Prediction of Sentinel Node Status and Clinical Outcome in a Melanoma Centre
Skin Cancer Volume 2013, Article ID 904701, 7 pages http://dx.doi.org/10.1155/2013/904701 Research Article Prediction of Sentinel Node Status and Clinical Outcome in a Melanoma Centre Vera Teixeira, 1
More informationMelanoma: The Basics. What is a melanocyte?
Melanoma: The Basics What is a melanocyte? A melanocyte is a normal cell, found in the skin, which produces melanin. Melanin is a black or dark brown pigment that is seen in the skin, hair, and parts of
More informationBenign and malignant epithelial lesions: Seborrheic keratosis: A common benign pigmented epidermal tumor occur in middle-aged or older persons more
Benign and malignant epithelial lesions: Seborrheic keratosis: A common benign pigmented epidermal tumor occur in middle-aged or older persons more common on the trunk; but extremities, head and neck are
More informationDa Costa was the first to coin the term. Marjolin s Ulcer: A Case Report and Literature Review. Case Report. Introduction
E-Da Medical Journal 2016;3(2):24-28 Case Report Marjolin s Ulcer: A Case Report and Literature Review Yue-Chiu Su 1, Li-Ren Chang 2 Marjolin s ulcer is an aggressive cutaneous malignancy, which is common
More informationFollicular Derived Thyroid Tumors
Follicular Derived Thyroid Tumors Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology Chair of Pathology and Laboratory Medicine University of Arkansas for Medical Sciences
More informationOcular Neoplasia What s Common? What s New? Richard R Dubielzig
Ocular Neoplasia What s Common? What s New? Richard R Dubielzig Orbit 288 6% Tumors of the globe make up 3225 out of 6110 total neoplasms = 53%. Tumors of the conjunctiva make up 1192 out of 6110 total
More informationToby Maurer, MD University of California, San Francisco. Lifetime risk of an American developing melanoma
Distinguishing Pigmented Skin Lesions and Melanoma Toby Maurer, MD University of California, San Francisco Epidemiology of Melanoma Lifetime risk of an American developing melanoma 1935: 1 in 1500 1980:
More informationAGGRESSIVE VARIANTS OF PAPILLARY THYROID CARCINOMA DIAGNOSIS AND PROGNOSIS
AGGRESSIVE VARIANTS OF PAPILLARY THYROID CARCINOMA DIAGNOSIS AND PROGNOSIS PAPILLARY THYROID CARCINOMA Clinical Any age Microscopic to large Female: Male= 2-4:1 Radiation history Lymph nodes Prognosis
More informationSurgery for Melanoma and What s on the Horizon
and What s on the Horizon Giorgos C. Karakousis, M.D. Assistant Professor of Surgery Perelman School of Medicine at the University of Pennsylvania Background/Overview 76,870 cases of melanoma estimated
More informationBenign versus Cancerous Lesions How to tell the difference FMF 2014 Christie Freeman MD, CCFP, DipPDerm, MSc
1 Benign versus Cancerous Lesions How to tell the difference FMF 2014 Christie Freeman MD, CCFP, DipPDerm, MSc Benign lesions Seborrheic Keratoses: Warty, stuck-on Genetics and birthdays Can start in late
More informationManagement of pediatric melanocytic lesions
Open Journal of Clinical & Medical Case Reports Management of pediatric melanocytic lesions Volume 3 (2017) Issue 8 ISSN 2379-1039 Jin Kim, BS; Emmanuel Gabriel MD, PhD; Weiguo Liu MD, PhD; Lin Lin MD,
More informationCitation Acta Medica Nagasakiensia. 1992, 37
NAOSITE: Nagasaki University's Ac Title Author(s) A Study on the Expression of EGFR a Content in the Stomach Cancer Tissu Nakazaki Takayuki Citation Acta Medica Nagasakiensia. 1992 37 Issue Date 1992-12-25
More informationPrimary Cutaneous CD30-Positive T-cell Lymphoproliferative Disorders
Primary Cutaneous CD30-Positive T-cell Lymphoproliferative Disorders Definition A spectrum of related conditions originating from transformed or activated CD30-positive T-lymphocytes May coexist in individual
More informationThe influence of tumour cell DNA content on survival in colorectal cancer: a detailed analysis
Br. J. Cancer (1990), 62, 852-856 Br. J. Cancer (1990), 62, 852-856 (~~~~~~~~~~~~~~~~~~~~~~) '." Macmillan Press Ltd., 1990 Macmillan Press Ltd., 1990~~~~~~~~~~~~~- The influence of tumour cell DNA content
More informationMelanoma Patients and the Sentinel Lymph Node (SLN) Procedure: An Oncologic Surgeon s Perspective
Melanoma Patients and the Sentinel Lymph Node (SLN) Procedure: An Oncologic Surgeon s Perspective Giorgos C. Karakousis, M.D. Associate Professor of Surgery Hospital of the University of Pennsylvania Disclosures
More informationNEW SURGICAL APPROACHES TO MELANOMA THERAPY
NEW SURGICAL APPROACHES TO MELANOMA THERAPY Melanoma 2003: New Insights Into Therapy & Treatment Douglas L. Fraker, M.D. University of Pennsylvania Surgical Treatment of Melanoma Primary resection margins
More informationORIGINAL ARTICLE PROGNOSTIC IMPLICATION OF SENTINEL LYMPH NODE BIOPSY IN CUTANEOUS HEAD AND NECK MELANOMA
ORIGINAL ARTICLE PROGNOSTIC IMPLICATION OF SENTINEL LYMPH NODE BIOPSY IN CUTANEOUS HEAD AND NECK MELANOMA Benjamin E. Saltman, MD, 1 Ian Ganly, MD, 2 Snehal G. Patel, MD, 2 Daniel G. Coit, MD, 3 Mary Sue
More informationMECHANISMS OF HUMAN DISEASE: LABORATORY SESSION PATHOLOGY OF THE SKIN LAB. Friday, February 12, :30 am 11:00 am
MECHANISMS OF HUMAN DISEASE: LABORATORY SESSION PATHOLOGY OF THE SKIN LAB Friday, February 12, 2012 9:30 am 11:00 am FACULTY COPY GOALS: Describe the basic clinical and morphologic features of various
More informationSelected Pseudomalignant Soft Tissue Tumors of the Skin and Subcutis
Selected Pseudomalignant Soft Tissue Tumors of the Skin and Subcutis Andrew L. Folpe, M.D. Professor of Laboratory Medicine and Pathology Mayo Clinic, Rochester, MN folpe.andrew@mayo.edu 2016 MFMER slide-1
More informationTumor Mitotic Rate Added to the Equation: Melanoma Prognostic Factors Changed?
Ann Surg Oncol (2015) 22:2978 2987 DOI 10.1245/s10434-014-4349-3 ORIGINAL ARTICLE MELANOMAS Tumor Mitotic Rate Added to the Equation: Melanoma Prognostic Factors Changed? A Single-Institution Database
More informationinvasive ductal breast cancer
J Clin Pathol 1987;40:1432-1436 Comparison of extent of disease and morphometric and DNA flow cytometric prognostic factors in invasive ductal breast cancer ANNE M UYTERLINDE, NELLIE W SCHIPPER, J P A
More informationSKIN CANCER. Most common cancer diagnosis 40% of all cancers
SKIN CANCER Most common cancer diagnosis 40% of all cancers OBJECTIVES Review common and uncommon cancers of the skin. Special emphasis on melanoma and dysplastic nevus Review pathology/tnm/staging, which
More informationMalignant Peripheral Nerve Sheath Tumor
C H A P T E R 120 Malignant Peripheral Nerve Sheath Tumor Currently, malignant peripheral nerve sheath tumor (MPNST) is the most commonly used generic name for the neoplasms known in the past as neurosarcoma,
More informationA superficial radiotherapy B single pass curettage C excision with 2 mm margins D excision with 5 mm margins E Mohs micrographic surgery.
1- A 63-year-old woman presents with a non-healing lesion on her right temple that has been present for over two years. On examination there is a 6 mm well defined lesion with central ulceration, telangiectasia
More informationMichael T. Tetzlaff MD, PhD
Update on American Joint Cancer Committee (AJCC) staging system for primary cutaneous melanoma Emphasis on concise and accurate reporting of primary and metastatic melanoma for effective risk stratification
More informationCarcinoma of the Lung
THE ANNALS OF THORACIC SURGERY Journal of The Society of Thoracic Surgeons and the Southern Thoracic Surgical Association VOLUME 1 I - NUMBER 3 0 MARCH 1971 Carcinoma of the Lung M. L. Dillon, M.D., and
More informationG3.02 The malignant potential of the neoplasm should be recorded. CG3.02a
G3.02 The malignant potential of the neoplasm should be recorded. CG3.02a Conventional adrenocortical neoplasm. Each of the below parameters is scored 0 when absent and 1 when present. 3 or more of these
More informationCarol Davila University of Medicine and Pharmacy, Bucharest, Romania b
Mædica - a Journal of Clinical Medicine MAEDICA a Journal of Clinical Medicine 2015; 10(3): 226-230 ORIGINAL PAPERS Improving Melanoma Path Reports: the Importance of Histopathological Parameters in Diagnosis
More informationBasaloid carcinoma of the anal canal
J. clin. Path. (1967), 0, 18 Basaloid carcinoma of the anal canal LILLIAN S. C. PANG AND B. C. MORSON From the Research Department, St. Mark's Hospital, London SYNOPSIS The pathology and results of treatment
More informationTBSRTC 1- Probabilistic approach and Relationship to Clinical Algorithms
The Benefits of a Uniform Reporting System for Thyroid Cytopathology BETHESDA REPORTING SYSTEM Prof. Fernando Schmitt Department of Pathology and Oncology, Medical Faculty of Porto University Head of Molecular
More informationSpinal Cord Compression caused by Metastatic Epithelial Myoepithelial Carcinoma of the Parotid Gland
Spinal Cord Compression caused by Metastatic Epithelial Myoepithelial Carcinoma of the Parotid Gland Pages with reference to book, From 249 To 250 Irshad N. Soomro,Akber S. Hussainy,Rashida Ahmed,Sheema
More informationManagement of recurrent phyllodes with full thickness chest wall resection
ORIGINAL ARTICLES Management of recurrent phyllodes with full thickness chest wall resection R Awwal a, SA Shashi b, MS Khondokar c, SH Khundkar d Abstract: Phyllodes tumours are biphasic fibroepithelial
More informationImpact of Prognostic Factors
Melanoma Prognostic Factors: where we started, where are we going? Impact of Prognostic Factors Staging Management Surgical intervention Adjuvant treatment Suraj Venna, MD Assistant Clinical Professor,
More information